ArticleHealth economics review2025

Cost-effectiveness analysis of combination therapies involving novel agents for first/second-relapse patients with multiple myeloma: a Markov model approach with calibration techniques.

Weijia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.